Literature DB >> 1548482

Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin.

L D Manley1, R Kuczenski, D S Segal, S J Young, P M Groves.   

Abstract

In vivo microdialysis was employed to detect changes in extracellular dopamine and serotonin in the rat caudate in response to electrical stimulation of the medial forebrain bundle. Extracellular dopamine concentrations increased linearly as a function of the frequency (4-33 Hz) of evenly spaced stimuli in both the presence and absence of cocaine added to the dialysate. Because dopamine neurons are known to fire in single-spike and burst patterns, stimulation pulses were also delivered in a bursting pattern. The response of extracellular dopamine was augmented in both the presence and absence of cocaine when the same number of stimuli were delivered in bursts as compared to an evenly spaced pattern. Serotonin, which was only assessed in the presence of cocaine, similarly increased linearly with frequency, but, in contrast to the dopamine response, levels of serotonin were not augmented by stimuli presented in bursts. These results suggest that microdialysis can be used to detect physiological changes in synaptic transmitter concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548482     DOI: 10.1111/j.1471-4159.1992.tb11369.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons.

Authors:  Y N Wu; K Z Shen; S W Johnson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.

Authors:  M Diana; M Pistis; S Carboni; G L Gessa; Z L Rossetti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.

Authors:  B M Prasad; S G Amara
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  Phosphoinositol metabolism affects AMP kinase-dependent K-ATP currents in rat substantia nigra dopamine neurons.

Authors:  Ke-Zhong Shen; Adam C Munhall; Steven W Johnson
Journal:  Brain Res       Date:  2018-10-26       Impact factor: 3.252

5.  Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity.

Authors:  Nicholas M Graziane; Abigail M Polter; Lisa A Briand; R Christopher Pierce; Julie A Kauer
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

6.  Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine.

Authors:  A Fink-Jensen; S H Ingwersen; P G Nielsen; L Hansen; E B Nielsen; A J Hansen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

7.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

8.  gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.

Authors:  G Engberg; H Nissbrandt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

9.  The dopamine hypothesis of drug addiction and its potential therapeutic value.

Authors:  Marco Diana
Journal:  Front Psychiatry       Date:  2011-11-29       Impact factor: 4.157

10.  Functional upregulation of Ca(2+)-activated K(+) channels in the development of substantia nigra dopamine neurons.

Authors:  José A Ramírez-Latorre
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.